| HANSOH PHARMACEUTICAL GROUP |
| China |
| Gesundheit |
| KYG549581067 / A2PLRC |
| 3KY (Frankfurt) |
| FRA:3KY, ETR:3KY, 3KY:GR |
| - |
| https://www.hansoh.cn/en/ |
|
Hansoh Pharmaceutical Group Co., Ltd. is a leading biopharmaceutical company that primarily specializes in the research, development, manufacturing, and sale of innovative therapeutics. The company focuses on addressing unmet medical needs in areas s..
>Volltext.. |
| 21568.74 Mio. EUR |
| 17299.65 Mio. EUR |
| 2016.64 Mio. EUR |
| 808.99 Mio. EUR |
| 851.06 Mio. EUR |
| 0.14 EUR |
| 554.92 Mio. EUR |
| 610.45 Mio. EUR |
| 914.22 Mio. EUR |
| 4.4 |
| 29.02% |
| 50.34% |
| 0.05 EUR |
| 1.55% |
| 1.55% |
| 22.09.26 - 0.03190005€ 03.07.26 - 0.022288€ >weitere anzeigen... |
| - |
| HANSOH |
| 20.10.26 |
|
||||
|
||||
|